Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Fortis Dengue Case:...

    Fortis Dengue Case: NPPA seeks bill copies from hospital

    Written by Ruby Khatun Khatun Published On 2017-11-25T09:15:44+05:30  |  Updated On 25 Nov 2017 9:15 AM IST
    Fortis Dengue Case: NPPA seeks bill copies from hospital

    New Delhi: The National Pharmaceutical Pricing Authority (NPPA) asked Fortis Healthcare to provide copies of bills in relation to the case of alleged overcharging of a dengue patient by its hospital in Gurugram.


    Reacting to reports that Fortis Gurugram charged approximately Rs. 16 lakh from Jayant Singh for treatment of dengue of his late daughter Adya, NPPA shot off a letter the company's CEO/MD seeking copies of invoices/bills raised, name of medicines administered along with details of quantity and price charged towards medicines and consumables.


    Citing the reports, NPPA in its letter said apart from the hospital charges, "the billing include the inflated cost of medicines, syringes and injectables etc".


    "NPPA is mandated to enquire and take action on cases wherever there is a violation of various provisions of the Drug Price Control order, 2013," it said in the letter.


    Cautioning the healthcare chain to respond with the information sought, NPPA said in case of failure, its team will inspect records of the hospital to collect information.


    When contacted, a Fortis Healthcare spokesperson told PTI the company has received the letter from NPPA and would respond to it within the December 6 deadline.


    NPPA's action comes a day after the Union Health Ministry asked all states to issue strict warnings and take action against hospitals, including private ones, which indulge in malpractices such as overcharging and do not follow standard treatment protocols.


    Earlier, Health Minister JP Nadda had sought a "detailed report" from the private hospital in the matter.


    Already, the Haryana government has set up a three-member committee to probe allegations that Gurugram's Fortis Hospital overcharged the family of the 7-year-old girl, who died of dengue.


    Union minister Ram Vilas Paswan has also weighed in, saying her parents should approach consumer court for adequate compensation.

    dengue patientFortis Dengue CaseFortis HealthcareFortis HospitalGurugramhospitalhospital chargeshospital newsinjectablesJp NaddaNational Pharmaceutical Pricing AuthorityNPPAoverchargingRam Vilas PaswansyringesUnion Health Ministry
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok